The soluble fms-like tyrosine kinase 1 (sFlt-1), known to be increased in the serum of preeclamptic patients, is a relevant factor in causing maternal symptoms like hypertension and proteinuria. In this study, we aimed to reveal whether hypoxia is a cause of increased sFlt-1 levels and inflammation markers in vivo and whether these symptoms can be attenuated by interleukin 6 (IL-6) depletion. For this purpose, pregnant wild-type (wt) mice or IL-6−/− mice on embryonic day 16 were placed under either normoxic (20.9% oxygen) or hypoxic (6% oxygen) conditions for 6 hours. This led to a rise of sFlt-1 levels in maternal serum, independent of the IL-6 status of the dam. Increased maternal sFlt-1 serum levels were, however, not due to an increase in sFlt-1 messenger RNA levels in the placenta. Moreover, there was no increase in inflammatory markers in neither wt mice nor IL-6−/− mice. This suggests that hypoxia alone does not contribute to the induction of an inflammatory placenta. Also, the hypoxia-induced rise in sFlt-1 levels seems not to be mediated by IL-6 in vivo.
KilburnBAWangJDuniec-DmuchowskiZMLeachRERomeroRArmantDR. Extracellular matrix composition and hypoxia regulate the expression of HLA-G and integrins in a human trophoblast cell line. Biol Reprod. 2000;62
(3):739–747.
2.
GrahamCHFitzpatrickTEMcCraeKR. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood. 1998;91
(9):3300–3307.
3.
JamesJLStonePRChamleyLW. The regulation of trophoblast differentiation by oxygen in the first trimester of pregnancy. Hum Reprod Update. 2006;12
(2):137–144.
4.
RodeschFSimonPDonnerCJauniauxE. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol. 1992;80
(2):283–285.
5.
IlekisJVReddyUMRobertsJM. Preeclampsia—a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci. 2007;14
(6):508–523.
6.
ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002;99
(1):159–167.
7.
GuzinKTomrukSTuncayYAThe relation of increased uterine artery blood flow resistance and impaired trophoblast invasion in pre-eclamptic pregnancies. Arch Gynecol Obstet. 2005;272
(4):283–288.
8.
NaickerTKhedunSMMoodleyJPijnenborgR. Quantitative analysis of trophoblast invasion in preeclampsia. Acta Obstet Gynecol Scand. 2003;82
(8):722–729.
9.
FisherSJ. The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol. 2004;2:53.
10.
LevineRJMaynardSEQianCCirculating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350
(7):672–683.
11.
RusterholzCHahnSHolzgreveW. Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol. 2007;29
(2):151–162.
12.
EnquobahrieDAMellerMRiceKPsatyBMSiscovickDSWilliamsMA. Differential placental gene expression in preeclampsia. Am J Obstet Gynecol. 2008;199(5):566. e561–e511.
13.
HennessyAPilmoreHLSimmonsLAPainterDM. A deficiency of placental IL-10 in preeclampsia. J Immunol. 1999;163
(6):3491–3495.
14.
BowenRSGuYZhangYLewisDFWangY. Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies. J Soc Gynecol Investig. 2005;12
(6):428–432.
15.
LockwoodCJYenCFBasarMPreeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am J Pathol. 2008;172
(6):1571–1579.
16.
BenyoDFMilesTMConradKP. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab. 1997;82
(5):1582–1588.
17.
HungTHCharnock-JonesDSSkepperJNBurtonGJ. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol. 2004;164
(3):1049–1061.
18.
RoyleCLimSXuBTooherJOgleRHennessyA. Effect of hypoxia and exogenous IL-10 on the pro-inflammatory cytokine TNF-alpha and the anti-angiogenic molecule soluble Flt-1 in placental villous explants. Cytokine. 2009;47
(1):56–60.
19.
PeltierMRGurzendaEMMurthyACan oxygen tension contribute to an abnormal placental cytokine milieu?Am J Reprod Immunol. 2011;66
(4):279–285.
20.
RajakumarAPowersRWHubelCANovel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women. Placenta. 2009;30
(1):25–34.
21.
GeorgeEMCockrellKAdairTHGrangerJP. Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants. Am J Physiol Regul Integr Comp Physiol. 2010;299
(6):R1629–R1633.
22.
NevoOSoleymanlouNWuYIncreased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol. 2006;291
(4):R1085–1093.
23.
WangGLJiangBHRueEASemenzaGL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. 1995;92
(12):5510–5514.
24.
LaiZKalkunteSSharmaS. A critical role of interleukin-10 in modulating hypoxia-induced preeclampsia-like disease in mice. Hypertension. 2011;57
(3):505–514.
25.
ZhouCCIraniRADaiYAutoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia. J Immunol. 2011;186
(10):6024–6034.
26.
TrollmannRStrasserKKellerSPlacental HIFs as markers of cerebral hypoxic distress in fetal mice. Am J Physiol Regul Integr Comp Physiol. 2008;295
(6):R1973–R1981.
27.
RotherEKuschewskiRAlcazarMAHypothalamic JNK1 and IKKbeta activation and impaired early postnatal glucose metabolism after maternal perinatal high-fat feeding. Endocrinology. 2012;153
(2):770–781.
28.
HegenMGaestelMNickerson-NutterCLLinLLTelliezJB. MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis. J Immunol. 2006;177
(3):1913–1917.
29.
YangJRosenSDBendelePHemmerichS. Induction of PNAd and N-acetylglucosamine 6-O-sulfotransferases 1 and 2 in mouse collagen-induced arthritis. BMC Immunol. 2006;7:12.
30.
HuckleWRRocheRI. Post-transcriptional control of expression of sFlt-1, an endogenous inhibitor of vascular endothelial growth factor. J Cell Biochem. 2004;93
(1):120–132.
WangARanaSKarumanchiSA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda). 2009;24:147–158.
33.
KimYNLeeDSJeongDHSungMSKimKT. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia. Prenat Diagn. 2009;29
(5):464–470.
HeYSmithSKDayKAClarkDELicenceDRCharnock-JonesDS. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol. 1999;13
(4):537–545.
36.
ZhaoSGuYFanRGroomeLJCooperDWangY. Proteases and sFlt-1 release in the human placenta. Placenta. 2010;31
(6):512–518.
37.
KendallRLThomasKA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA. 1993;90
(22):10705–10709.
38.
HerseFFainJNJankeJAdipose tissue-derived soluble fms-like tyrosine kinase 1 is an obesity-relevant endogenous paracrine adipokine. Hypertension. 2011;58
(1):37–42.
39.
LeeMCWeiSCTsai-WuJJWuCHTsaoPN. Novel PKC signaling is required for LPS-induced soluble Flt-1 expression in macrophages. J Leukoc Biol. 2008;84
(3):835–841.
van der PollTKeoghCVGuiraoXBuurmanWAKopfMLowrySF. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis. 1997;176
(2):439–444.
